NeuroSense Therapeutics Ltd. Proceeds from Issuance of Private Placement
NeuroSense Therapeutics Ltd. (NRSN) had Proceeds from Issuance of Private Placement of $4.50 million as of 2023-06-22, per its 6-K filed 2024-06-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-06-17
- 2023-06-22: Proceeds from Issuance of Private Placement $4.50M.
| Period end | Proceeds from Issuance of Private Placement |
|---|---|
| 2023-06-22 | $4.50M 6-K · filed 2024-06-17 |